ENZON PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Enzon Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 6.14K %.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 6.14K Jun 30, 2024
Q1 2024 6.15K Mar 31, 2024
Q4 2023 6.38K Dec 31, 2023
Q3 2023 6.42K Sep 30, 2023
Q1 2021 5.55K +5.05K +1025% Mar 31, 2021
Q4 2020 3.46K +2.9K +522% Dec 31, 2020
Q3 2020 1.25K +582 +87.5% Sep 30, 2020
Q2 2020 417 -1.62K -79.5% Jun 30, 2020
Q1 2020 493 -1.41K -74.1% Mar 31, 2020
Q4 2019 556 -1.24K -69.1% Dec 31, 2019
Q3 2019 666 -901 -57.5% Sep 30, 2019
Q2 2019 2.03K +149 +7.89% Jun 30, 2019
Q1 2019 1.9K -323 -14.5% Mar 31, 2019
Q4 2018 1.8K -698 -27.9% Dec 31, 2018
Q3 2018 1.57K -273 -14.8% Sep 30, 2018
Q2 2018 1.89K -428 -18.5% Jun 30, 2018
Q1 2018 2.22K -374 -14.4% Mar 31, 2018
Q4 2017 2.5K -307 -10.9% Dec 31, 2017
Q3 2017 1.84K +980 +114% Sep 30, 2017
Q2 2017 2.31K +1.78K +330% Jun 30, 2017
Q1 2017 2.6K +2.34K +927% Mar 31, 2017
Q4 2016 2.8K +2.48K +757% Dec 31, 2016
Q3 2016 860 +465 +118% Sep 30, 2016
Q2 2016 538 Jun 30, 2016
Q1 2016 253 Mar 31, 2016
Q4 2015 327 Dec 31, 2015
Q3 2015 395 Sep 30, 2015
Q4 2013 191 -1.01 -0.53% Dec 31, 2013
Q3 2013 175 -79 -31.1% Sep 30, 2013
Q2 2013 187 -264 -58.5% Jun 30, 2013
Q1 2013 164 -1.62K -90.8% Mar 31, 2013
Q4 2012 192 Dec 31, 2012
Q3 2012 254 Sep 30, 2012
Q2 2012 451 Jun 30, 2012
Q1 2012 1.78K Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.